Defense Diagnostics Inc (DDI), a Los Angeles-based medical diagnostics company, announced on Tuesday that it has introduced its DEFENT ONE All-In-One Fentanyl Detection Device, claimed to be the world's first and only patent-pending, portable detection device, in the United States.

The new device is designed to make testing substances quick, accurate and easy, anytime and anywhere and aims to reduce overdoses by normalising substance testing in all environments. It features a compact, durable design with tools such as a pre-measured scoop, deionised water, clear result lines and user-friendly instructions.

DEFENT ONE can be purchased at DEFENT.com and will soon be available on Amazon.

Ahmad Hussain, DEFENT CEO and founder, said: "Our team has dedicated the last two years to developing the most user-friendly testing device with one goal in mind: putting an end to accidental overdose deaths. Too many of us have experienced the pain of losing loved ones to a single, avoidable mistake. Our next step is to ensure widespread accessibility to DEFENT ONE by partnering with various retail channels and advocating for government organisations to allocate opioid settlement funds toward their intended purpose. Currently, funding has predominantly been directed toward effective reactive solutions, like Narcan, while insufficient attention is being given to preventative measures."